EWTX
Edgewise Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$43.07
+2.67%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-44.0%
Return on equity
-41.1%
Return on assets
-48.5%
Return on invested capital
0.00x
Asset turnover
-$159.4M
Cash from operations
$4.24
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026